Literature DB >> 31705561

Full axillary lymph node dissection and increased breast epidermal thickness 1 year after radiation therapy for breast cancer.

Jolinta Y Lin1,2, Xiaofeng Yang1,2, Monica Serra2,3, Andrew H Miller2,4, Karen D Godette1,2, Shannon T Kahn1,2, Simone Henry1,2, Gabrielle Brown1,2, Tian Liu1,2, Mylin A Torres1,2.   

Abstract

BACKGROUND: We previously reported a prospective study showing axillary lymph node dissection (ALND) is associated with increased breast skin thickening during and 6 weeks post-radiation therapy (RT), and now report ALND's long-term impact at 1 year.
METHODS: Among 66 women who received whole breast RT after lumpectomy, objective ultrasound measurements of epidermal thickness over four quadrants of the treated breast were measured at five time points: before RT, week 6 of RT, and 6 weeks, 6 months, and 1 year post-RT. Skin thickness ratio (STRA) was generated by normalizing for corresponding measurements of the contralateral breast.
RESULTS: A total of 2,436 ultrasound images were obtained. Among 63 women with evaluable data at 1 year, mean STRA significantly increased at 6 months (absolute mean increase of 65%, SD 0.054), and remained elevated at 1 year post-RT (absolute mean increase of 44%, SD 0.048). In multivariable analysis, ALND compared to sentinel lymph node biopsy, longer interval between surgery and RT, increased baseline STRA, and Caucasian race predicted for more severe changes in STRA at 1 year compared to baseline (all P < .05).
CONCLUSIONS: In the setting of whole breast RT, our findings suggest that ALND has long-term repercussions on breast skin thickening.
© 2019 Wiley Periodicals, Inc.

Entities:  

Keywords:  breast cancer; lymph node dissection; radiation therapy; skin thickening; toxicity

Mesh:

Year:  2019        PMID: 31705561      PMCID: PMC8015418          DOI: 10.1002/jso.25757

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  24 in total

1.  Automated skin segmentation in ultrasonic evaluation of skin toxicity in breast cancer radiotherapy.

Authors:  Yi Gao; Allen Tannenbaum; Hao Chen; Mylin Torres; Emi Yoshida; Xiaofeng Yang; Yuefeng Wang; Walter Curran; Tian Liu
Journal:  Ultrasound Med Biol       Date:  2013-08-27       Impact factor: 2.998

2.  Quantitative ultrasonic evaluation of radiation-induced late tissue toxicity: pilot study of breast cancer radiotherapy.

Authors:  Tian Liu; Jun Zhou; Emi J Yoshida; Shermian A Woodhouse; Peter B Schiff; Tony J C Wang; Zheng Feng Lu; Eliza Pile-Spellman; Pengpeng Zhang; Gerald J Kutcher
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-02-19       Impact factor: 7.038

3.  Long-term results of hypofractionated radiation therapy for breast cancer.

Authors:  Timothy J Whelan; Jean-Philippe Pignol; Mark N Levine; Jim A Julian; Robert MacKenzie; Sameer Parpia; Wendy Shelley; Laval Grimard; Julie Bowen; Himu Lukka; Francisco Perera; Anthony Fyles; Ken Schneider; Sunil Gulavita; Carolyn Freeman
Journal:  N Engl J Med       Date:  2010-02-11       Impact factor: 91.245

4.  Large breast size as a risk factor for late adverse effects of breast radiotherapy: is residual dose inhomogeneity, despite 3D treatment planning and delivery, the main explanation?

Authors:  Christy Goldsmith; Joanne Haviland; Yat Tsang; Mark Sydenham; John Yarnold
Journal:  Radiother Oncol       Date:  2011-02-04       Impact factor: 6.280

5.  Reliability of quantitative ultrasonic assessment of normal-tissue toxicity in breast cancer radiotherapy.

Authors:  Emi J Yoshida; Hao Chen; Mylin Torres; Fundagul Andic; Hao-Yang Liu; Zhengjia Chen; Xiaoyan Sun; Walter J Curran; Tian Liu
Journal:  Int J Radiat Oncol Biol Phys       Date:  2011-03-23       Impact factor: 7.038

Review 6.  Radiation-induced fibrosis: mechanisms and implications for therapy.

Authors:  Jeffrey M Straub; Jacob New; Chase D Hamilton; Chris Lominska; Yelizaveta Shnayder; Sufi M Thomas
Journal:  J Cancer Res Clin Oncol       Date:  2015-04-25       Impact factor: 4.553

7.  Randomized trial of pentoxifylline and vitamin E vs standard follow-up after breast irradiation to prevent breast fibrosis, evaluated by tissue compliance meter.

Authors:  Geraldine Jacobson; Sudershan Bhatia; Brian J Smith; Anna M Button; Kellie Bodeker; John Buatti
Journal:  Int J Radiat Oncol Biol Phys       Date:  2012-07-28       Impact factor: 7.038

8.  Three-Year Outcomes With Hypofractionated Versus Conventionally Fractionated Whole-Breast Irradiation: Results of a Randomized, Noninferiority Clinical Trial.

Authors:  Simona F Shaitelman; Xiudong Lei; Alastair Thompson; Pamela Schlembach; Elizabeth S Bloom; Isidora Y Arzu; Daniel Buchholz; Gregory Chronowski; Tomas Dvorak; Emily Grade; Karen Hoffman; George Perkins; Valerie K Reed; Shalin J Shah; Michael C Stauder; Eric A Strom; Welela Tereffe; Wendy A Woodward; Diana N Amaya; Yu Shen; Gabriel N Hortobagyi; Kelly K Hunt; Thomas A Buchholz; Benjamin D Smith
Journal:  J Clin Oncol       Date:  2018-10-31       Impact factor: 44.544

9.  Normal tissue complication probability (NTCP) parameters for breast fibrosis: pooled results from two randomised trials.

Authors:  Mukesh B Mukesh; Emma Harris; Sandra Collette; Charlotte E Coles; Harry Bartelink; Jenny Wilkinson; Philip M Evans; Peter Graham; Jo Haviland; Philip Poortmans; John Yarnold; Raj Jena
Journal:  Radiother Oncol       Date:  2013-08-13       Impact factor: 6.280

10.  The UK Standardisation of Breast Radiotherapy (START) trials of radiotherapy hypofractionation for treatment of early breast cancer: 10-year follow-up results of two randomised controlled trials.

Authors:  Joanne S Haviland; J Roger Owen; John A Dewar; Rajiv K Agrawal; Jane Barrett; Peter J Barrett-Lee; H Jane Dobbs; Penelope Hopwood; Pat A Lawton; Brian J Magee; Judith Mills; Sandra Simmons; Mark A Sydenham; Karen Venables; Judith M Bliss; John R Yarnold
Journal:  Lancet Oncol       Date:  2013-09-19       Impact factor: 41.316

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.